Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

NCT03587272 is registered in ClinicalTrials.gov with Robert Nickel as lead sponsor.

NCT NCT03587272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03587272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Lead sponsor
Robert Nickel
Phase
Phase 2
Overall status
Recruiting
Start date
April 17, 2018
Completion date
November 30, 2030
Enrollment
100 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease